vs
LifeStance Health Group, Inc.（LFST）与SelectQuote, Inc.（SLQT）财务数据对比。点击上方公司名可切换其他公司
SelectQuote, Inc.的季度营收约是LifeStance Health Group, Inc.的1.4倍（$537.1M vs $382.2M），SelectQuote, Inc.净利率更高（12.9% vs 3.1%，领先9.8%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 11.6%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $-1.0M），过去两年SelectQuote, Inc.的营收复合增速更高（19.5% vs 12.8%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
SelectQuote是面向消费者的直售平台，主营保险产品与医疗服务业务，通过对接消费者与保险机构获取佣金，覆盖长者健康险、人寿险、车险、家财险等品类，医疗服务板块以认证药房SelectRx为核心业务，公司于2020年5月上市。
LFST vs SLQT — 直观对比
营收规模更大
SLQT
是对方的1.4倍
$382.2M
营收增速更快
LFST
高出5.8%
11.6%
净利率更高
SLQT
高出9.8%
3.1%
自由现金流更多
LFST
多$47.7M
$-1.0M
两年增速更快
SLQT
近两年复合增速
12.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $382.2M | $537.1M |
| 净利润 | $11.7M | $69.3M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 4.7% | 14.0% |
| 净利率 | 3.1% | 12.9% |
| 营收同比 | 17.4% | 11.6% |
| 净利润同比 | 264.1% | 30.2% |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFSTSLQT
| Q4 25 | $382.2M | $537.1M | ||
| Q3 25 | $363.8M | $328.8M | ||
| Q2 25 | $345.3M | $345.1M | ||
| Q1 25 | $333.0M | $408.2M | ||
| Q4 24 | $325.5M | $481.1M | ||
| Q3 24 | $312.7M | $292.3M | ||
| Q2 24 | $312.3M | $307.2M | ||
| Q1 24 | $300.4M | $376.4M |
净利润LFSTSLQT
| Q4 25 | $11.7M | $69.3M | ||
| Q3 25 | $1.1M | $-30.5M | ||
| Q2 25 | $-3.8M | $12.9M | ||
| Q1 25 | $709.0K | $26.0M | ||
| Q4 24 | $-7.1M | $53.2M | ||
| Q3 24 | $-6.0M | $-44.5M | ||
| Q2 24 | $-23.3M | $-31.0M | ||
| Q1 24 | $-21.1M | $8.6M |
毛利率LFSTSLQT
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 41.4% | ||
| Q2 25 | — | 47.2% | ||
| Q1 25 | — | 60.2% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 55.7% | ||
| Q2 24 | — | 60.7% | ||
| Q1 24 | — | 71.8% |
营业利润率LFSTSLQT
| Q4 25 | 4.7% | 14.0% | ||
| Q3 25 | 2.0% | -12.4% | ||
| Q2 25 | -0.9% | -3.6% | ||
| Q1 25 | 0.5% | 5.4% | ||
| Q4 24 | 0.3% | 14.7% | ||
| Q3 24 | 0.0% | -4.1% | ||
| Q2 24 | -5.1% | -0.5% | ||
| Q1 24 | -5.6% | 8.8% |
净利率LFSTSLQT
| Q4 25 | 3.1% | 12.9% | ||
| Q3 25 | 0.3% | -9.3% | ||
| Q2 25 | -1.1% | 3.7% | ||
| Q1 25 | 0.2% | 6.4% | ||
| Q4 24 | -2.2% | 11.1% | ||
| Q3 24 | -1.9% | -15.2% | ||
| Q2 24 | -7.5% | -10.1% | ||
| Q1 24 | -7.0% | 2.3% |
每股收益（稀释后）LFSTSLQT
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $-0.26 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.30 | ||
| Q3 24 | — | $-0.26 | ||
| Q2 24 | — | $-0.17 | ||
| Q1 24 | — | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $248.6M | $18.3M |
| 总债务越低越好 | $282.8M | $405.8M |
| 股东权益账面价值 | $1.5B | $359.7M |
| 总资产 | $2.2B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.19× | 1.13× |
8季度趋势，按日历期对齐
现金及短期投资LFSTSLQT
| Q4 25 | $248.6M | $18.3M | ||
| Q3 25 | $203.9M | $10.7M | ||
| Q2 25 | $188.9M | $32.4M | ||
| Q1 25 | $134.3M | $80.1M | ||
| Q4 24 | $154.6M | $7.3M | ||
| Q3 24 | $102.6M | $10.4M | ||
| Q2 24 | $87.0M | $42.7M | ||
| Q1 24 | $49.5M | $37.8M |
总债务LFSTSLQT
| Q4 25 | $282.8M | $405.8M | ||
| Q3 25 | $284.6M | $393.1M | ||
| Q2 25 | $286.4M | $385.1M | ||
| Q1 25 | $288.2M | $391.5M | ||
| Q4 24 | $290.0M | $711.9M | ||
| Q3 24 | $287.3M | $680.4M | ||
| Q2 24 | $288.0M | $683.3M | ||
| Q1 24 | $288.8M | $686.0M |
股东权益LFSTSLQT
| Q4 25 | $1.5B | $359.7M | ||
| Q3 25 | $1.5B | $305.1M | ||
| Q2 25 | $1.5B | $351.1M | ||
| Q1 25 | $1.5B | $350.2M | ||
| Q4 24 | $1.4B | $326.0M | ||
| Q3 24 | $1.4B | $269.4M | ||
| Q2 24 | $1.4B | $316.8M | ||
| Q1 24 | $1.4B | $346.8M |
总资产LFSTSLQT
| Q4 25 | $2.2B | $1.4B | ||
| Q3 25 | $2.1B | $1.2B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.1B | $1.3B | ||
| Q4 24 | $2.1B | $1.3B | ||
| Q3 24 | $2.1B | $1.1B | ||
| Q2 24 | $2.1B | $1.2B | ||
| Q1 24 | $2.1B | $1.2B |
负债/权益比LFSTSLQT
| Q4 25 | 0.19× | 1.13× | ||
| Q3 25 | 0.19× | 1.29× | ||
| Q2 25 | 0.19× | 1.10× | ||
| Q1 25 | 0.20× | 1.12× | ||
| Q4 24 | 0.20× | 2.18× | ||
| Q3 24 | 0.20× | 2.53× | ||
| Q2 24 | 0.20× | 2.16× | ||
| Q1 24 | 0.20× | 1.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.6M | $52.0K |
| 自由现金流经营现金流 - 资本支出 | $46.6M | $-1.0M |
| 自由现金流率自由现金流/营收 | 12.2% | -0.2% |
| 资本支出强度资本支出/营收 | 2.9% | 0.2% |
| 现金转化率经营现金流/净利润 | 4.93× | 0.00× |
| 过去12个月自由现金流最近4个季度 | $110.0M | $8.5M |
8季度趋势，按日历期对齐
经营现金流LFSTSLQT
| Q4 25 | $57.6M | $52.0K | ||
| Q3 25 | $27.3M | $-21.6M | ||
| Q2 25 | $64.4M | $-37.5M | ||
| Q1 25 | $-3.1M | $71.1M | ||
| Q4 24 | $62.3M | $-28.7M | ||
| Q3 24 | $22.7M | $-16.6M | ||
| Q2 24 | $44.1M | $20.0M | ||
| Q1 24 | $-21.8M | $44.5M |
自由现金流LFSTSLQT
| Q4 25 | $46.6M | $-1.0M | ||
| Q3 25 | $17.0M | $-22.7M | ||
| Q2 25 | $56.6M | $-38.0M | ||
| Q1 25 | $-10.3M | $70.2M | ||
| Q4 24 | $56.0M | $-29.0M | ||
| Q3 24 | $17.7M | $-17.1M | ||
| Q2 24 | $39.0M | $19.7M | ||
| Q1 24 | $-26.9M | $43.4M |
自由现金流率LFSTSLQT
| Q4 25 | 12.2% | -0.2% | ||
| Q3 25 | 4.7% | -6.9% | ||
| Q2 25 | 16.4% | -11.0% | ||
| Q1 25 | -3.1% | 17.2% | ||
| Q4 24 | 17.2% | -6.0% | ||
| Q3 24 | 5.7% | -5.8% | ||
| Q2 24 | 12.5% | 6.4% | ||
| Q1 24 | -9.0% | 11.5% |
资本支出强度LFSTSLQT
| Q4 25 | 2.9% | 0.2% | ||
| Q3 25 | 2.8% | 0.3% | ||
| Q2 25 | 2.2% | 0.1% | ||
| Q1 25 | 2.2% | 0.2% | ||
| Q4 24 | 1.9% | 0.1% | ||
| Q3 24 | 1.6% | 0.2% | ||
| Q2 24 | 1.6% | 0.1% | ||
| Q1 24 | 1.7% | 0.3% |
现金转化率LFSTSLQT
| Q4 25 | 4.93× | 0.00× | ||
| Q3 25 | 25.34× | — | ||
| Q2 25 | — | -2.91× | ||
| Q1 25 | -4.36× | 2.73× | ||
| Q4 24 | — | -0.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFST
暂无分部数据
SLQT
| Healthcare Services Segment | $230.7M | 43% |
| Pharmacy | $227.2M | 42% |
| Other | $30.4M | 6% |
| Final Expense | $20.4M | 4% |
| Term | $18.5M | 3% |
| Other Senior | $6.3M | 1% |
| All Other Revenue | $3.9M | 1% |
